Guggenheim Capital’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,855
Closed -$482K 1921
2024
Q2
$482K Buy
+16,855
New +$482K ﹤0.01% 1447
2023
Q3
Sell
-47,229
Closed -$1.89M 1896
2023
Q2
$1.89M Buy
47,229
+4
+0% +$160 0.01% 878
2023
Q1
$1.93M Sell
47,225
-1,744
-4% -$71.2K 0.02% 857
2022
Q4
$1.89M Buy
+48,969
New +$1.89M 0.02% 876
2022
Q2
Sell
-65,765
Closed -$5.02M 2112
2022
Q1
$5.02M Buy
65,765
+1,305
+2% +$99.6K 0.03% 651
2021
Q4
$3.88M Sell
64,460
-27,408
-30% -$1.65M 0.02% 784
2021
Q3
$5.15M Sell
91,868
-2,482
-3% -$139K 0.03% 646
2021
Q2
$5.73M Buy
94,350
+64,284
+214% +$3.9M 0.03% 626
2021
Q1
$2.11M Sell
30,066
-9,243
-24% -$648K 0.01% 1001
2020
Q4
$2.35M Buy
+39,309
New +$2.35M 0.01% 897
2018
Q4
Sell
-52,296
Closed -$2.57M 2321
2018
Q3
$2.57M Sell
52,296
-8,949
-15% -$440K 0.02% 1100
2018
Q2
$1.96M Sell
61,245
-7,461
-11% -$239K 0.01% 1267
2018
Q1
$2.14M Buy
68,706
+12,112
+21% +$377K 0.01% 1583
2017
Q4
$2.58M Sell
56,594
-22,528
-28% -$1.03M 0.01% 1475
2017
Q3
$2.97M Buy
79,122
+13,255
+20% +$498K 0.01% 1388
2017
Q2
$3.14M Buy
65,867
+10,557
+19% +$504K 0.01% 1292
2017
Q1
$2.52M Sell
55,310
-13,278
-19% -$606K 0.01% 1483
2016
Q4
$2.22M Sell
68,588
-239
-0.3% -$7.72K 0.01% 1595
2016
Q3
$2.36M Sell
68,827
-2,141
-3% -$73.3K 0.01% 1515
2016
Q2
$2.39M Buy
70,968
+5,790
+9% +$195K 0.01% 1452
2016
Q1
$3.45M Buy
65,178
+22,368
+52% +$1.19M 0.01% 1205
2015
Q4
$3.29M Buy
42,810
+33,606
+365% +$2.58M 0.01% 1265
2015
Q3
$378K Sell
9,204
-40,747
-82% -$1.67M ﹤0.01% 2509
2015
Q2
$3.53M Buy
49,951
+7,819
+19% +$553K 0.01% 1348
2015
Q1
$3.74M Buy
42,132
+8,642
+26% +$768K 0.01% 1322
2014
Q4
$2.97M Buy
33,490
+20,339
+155% +$1.8M 0.01% 1441
2014
Q3
$1.28M Buy
13,151
+2,046
+18% +$198K ﹤0.01% 2044
2014
Q2
$1.02M Buy
+11,105
New +$1.02M ﹤0.01% 2217
2013
Q3
Sell
-21,406
Closed -$621K 3053
2013
Q2
$621K Buy
+21,406
New +$621K ﹤0.01% 2253